Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)
India · Delayed Price · Currency is INR 222.00
+2.00 (0.91%)
At close: Feb 12, 2026
NSE:MADHAVBAUG Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 979.9 | 898.47 | 993.31 | 991.69 | 747.11 | 522.75 | |
Revenue Growth (YoY) | 8.84% | -9.55% | 0.16% | 32.74% | 42.92% | -30.51% |
Cost of Revenue | 170.98 | 180.16 | 279.61 | 298.93 | 241.25 | 180.94 |
Gross Profit | 808.91 | 718.31 | 713.7 | 692.76 | 505.86 | 341.8 |
Selling, General & Admin | 386.42 | 394.62 | 456.23 | 423.06 | 267.72 | 166.15 |
Other Operating Expenses | 258.88 | 188.66 | 212.44 | 191.13 | 167.11 | 131.72 |
Operating Expenses | 699.18 | 624.83 | 700.09 | 640.17 | 457.68 | 322.35 |
Operating Income | 109.73 | 93.48 | 13.62 | 52.59 | 48.18 | 19.45 |
Interest Expense | -1.31 | -1.04 | -2.48 | -1.88 | -2.02 | -3.03 |
Interest & Investment Income | 14.94 | 14.94 | 9.04 | 8.73 | 1.47 | 0.05 |
Earnings From Equity Investments | -0.1 | -0.17 | -0.11 | - | - | - |
Other Non Operating Income (Expenses) | 4.8 | 3.64 | 4.98 | 4.89 | -0 | -0 |
EBT Excluding Unusual Items | 128.06 | 110.85 | 25.04 | 64.33 | 47.64 | 16.47 |
Gain (Loss) on Sale of Investments | - | - | 3.42 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.07 | - | - | - |
Other Unusual Items | -12.03 | -12.03 | - | - | -0.15 | -11.92 |
Pretax Income | 116.03 | 98.82 | 28.54 | 64.33 | 47.49 | 4.55 |
Income Tax Expense | 33.95 | 27.45 | 8.74 | 16 | 12.8 | 0.63 |
Earnings From Continuing Operations | 82.08 | 71.37 | 19.79 | 48.33 | 34.69 | 3.92 |
Minority Interest in Earnings | 0.01 | -0.01 | 0.01 | -0.01 | - | - |
Net Income | 82.09 | 71.36 | 19.8 | 48.33 | 34.69 | 3.92 |
Net Income to Common | 82.09 | 71.36 | 19.8 | 48.33 | 34.69 | 3.92 |
Net Income Growth | 102.61% | 260.34% | -59.02% | 39.32% | 784.92% | - |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 7 |
Shares Outstanding (Diluted) | 11 | 12 | 12 | 11 | 11 | 7 |
Shares Change (YoY) | -38.55% | - | 17.37% | - | 50.73% | - |
EPS (Basic) | 7.76 | 6.79 | 1.88 | 4.60 | 3.30 | 0.56 |
EPS (Diluted) | 7.76 | 5.81 | 1.57 | 4.60 | 3.30 | 0.56 |
EPS Growth | 229.31% | 270.06% | -65.85% | 39.32% | 487.10% | - |
Free Cash Flow | 49.45 | 21.55 | -124.09 | -69.15 | -162.95 | 48.51 |
Free Cash Flow Per Share | 4.67 | 1.75 | -10.06 | -6.58 | -15.50 | 6.96 |
Dividend Per Share | - | - | - | 0.500 | - | - |
Gross Margin | 82.55% | 79.95% | 71.85% | 69.86% | 67.71% | 65.39% |
Operating Margin | 11.20% | 10.40% | 1.37% | 5.30% | 6.45% | 3.72% |
Profit Margin | 8.38% | 7.94% | 1.99% | 4.87% | 4.64% | 0.75% |
Free Cash Flow Margin | 5.05% | 2.40% | -12.49% | -6.97% | -21.81% | 9.28% |
EBITDA | 160.35 | 133.41 | 45.03 | 78.57 | 68.68 | 43.93 |
EBITDA Margin | 16.36% | 14.85% | 4.53% | 7.92% | 9.19% | 8.40% |
D&A For EBITDA | 50.62 | 39.93 | 31.42 | 25.98 | 20.5 | 24.47 |
EBIT | 109.73 | 93.48 | 13.62 | 52.59 | 48.18 | 19.45 |
EBIT Margin | 11.20% | 10.40% | 1.37% | 5.30% | 6.45% | 3.72% |
Effective Tax Rate | 29.26% | 27.78% | 30.64% | 24.87% | 26.95% | 13.81% |
Revenue as Reported | 999.64 | 917.05 | 1,011 | 1,005 | 750.49 | 523.77 |
Advertising Expenses | - | 140.94 | 137.62 | 159.29 | 85.94 | 32.59 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.